Skip to main content
Log in

Separation and quantitative determination of 6α-hydroxycortisol and 6β-hydroxycortisol in human urine by high-performance liquid chromatography with ultraviolet absorption detection

  • Original Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

The present study developed an high-performance liquid chromatography (HPLC) method for the simultaneous determination of urinary metabolites of endogenous cortisol, 6α-hydroxycortisol (6α-OHF) and 6β-hydroxycortisol (6β-OHF), in human urine, using 6α-hydroxycorticosterone as internal standard. 6α-OHF and 6β-OHF were extracted from urine with ethyl acetate by using a Sep-Pak C18 plus cartridge. Separation of the stereoisomers was achieved on a reversed-phase hybrid column by a gradient elution of (A) 0.05 M KH2PO4–0.01 M CH3COOH (pH 3.77) and (B) 0.05 M KH2PO4–0.01 M CH3COOH/acetonitrile (2:3, v/v). 6α-OHF and 6β-OHF were well separated on an XTerra MS C18 5 μm column using two types of stepwise gradient elution program (programs 2 and 3). Resolutions of 6α-OHF and 6β-OHF were Rs = 4.41 for program 2 and Rs = 4.60 for program 3. The analysis was performed within 23~26 min, monitored by UV absorbance at 239 nm. The lower limits of detection of 6α-OHF and 6β-OHF were 0.80 ng per injection (s/n = ca. 8), and the lower limits of quantification were 5.02 ng/ml for 6α-OHF and 41.08 ng/ml for 6β-OHF, respectively. The within-day reproducibilities in the amounts of 6α-OHF and 6β-OHF determined were in good agreement with the actual amounts added, the relative errors being −5.37% and −3.73% (gradient 2) and −5.69% and −3.96% (gradient 3) for both 6α-OHF and 6β-OHF, respectively. The inter-assay precisions (RSDs) for 6α-OHF and 6β-OHF were less than 1.99% (gradient 2) and 2.61% (gradient 3), respectively. The present HPLC method was applied to the measurement of 6α-OHF and 6β-OHF in urine to evaluate the time courses of 6α-hydroxylation and 6β-hydroxylation clearances of cortisol during 40 days for phenotyping CYP3A in a healthy subject.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Watkins PB (1994) Noninvasive tests of CYP3A enzymes. Pharmacogenetics 4:171–184

    Article  CAS  Google Scholar 

  2. Wilkinson GR (1996) Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans. J Pharmacokinet Biopharm 24:475–490

    Article  CAS  Google Scholar 

  3. Streetman DS, Bertino JS Jr, Nafziger AN (2000) Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. Pharmacogenetics 10:187–216

    Article  CAS  Google Scholar 

  4. Ged C, Rouillon JM, Pichard L, Combalbert J, Bressot N, Bories P, Michel H, Beaune P, Maurel P (1989) The increase in urinary excretion of 6β-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction. Br J Clin Pharmacol 28:373–387

    CAS  Google Scholar 

  5. Monsarrat B, Chatelut E, Royer I, Alvinerie P, Dubois J, Dezeuse A, Roche H, Cros S, Wright M, Canal P (1998) Modification of paclitaxel metabolism in a cancer patient by induction of cytochrome P450 3A4. Drug Metab Dispos 26:229–233

    CAS  Google Scholar 

  6. Pichard-Garcia L, Hyland R, Baulieu J, Fabre J-M, Milton A, Maurel P (2000) Human hepatocytes in primary culture predict lack of cytochrome P-450 3A4 induction by eletriptan in vivo. Drug Metab Dispos 28:51–57

    CAS  Google Scholar 

  7. Furuta T, Suzuki A, Shibasaki H, Yokokawa A, Kasuya Y (2001) Urinary 6β-hydroxycortisol/cortisol ratio does not reflect in vivo CYP3A activity in humans. Xenobio Metab Dispos 16(Suppl):S98–S99

    Google Scholar 

  8. Furuta T, Suzuki A, Mori C, Shibasaki H, Yokokawa A, Kasuya Y (2003) Evidence for the validity of cortisol 6β-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotying in humans. Drug Metab Dispos 31:1283–1287

    Article  CAS  Google Scholar 

  9. Kishida S, Fukushima DK (1977) Radioimmunoassay of 6β-hydroxycortisol in human plasma and urine. Steroids 30:741–749

    Article  CAS  Google Scholar 

  10. Park BK (1978) A direct radioimmunoassay for 6β-hydroxycortisol in human urine. J Steroid Biochem 9:963–966

    Article  CAS  Google Scholar 

  11. Nahoul K, Adeline J, Paysant F, Scholler R (1982) Radioimmunoassay of plasma and urine 6β-hydroxycortisol: levels in healthy adults and in hypercortisolemic states. J Steroid Biochem 17:343–350

    Article  CAS  Google Scholar 

  12. Zhiri A, Mayer HA, Michaux V, Wellman-Bednawska M, Siest G (1986) 6β-Hydroxycortisol in serum and urine as determined by enzyme immunoassay on microtitre plates. Clin Chem 32:2094–2097

    CAS  Google Scholar 

  13. Lee C (1995) Urinary 6β-hydroxycortisol in humans: analysis, biological variations, and reference ranges. Clin Biochem 28:49–54

    Article  CAS  Google Scholar 

  14. Goto J, Shamsa F, Nambara T (1983) Studies on steroids CLXXXII. Determination of 6β-hydroxycortisol in urine by high-performance liquid chromatography with fluorescence detection. J Liquid Chromatogr 6:1977–1985

    Article  CAS  Google Scholar 

  15. Ono T, Tanida K, Shibata H, Konishi H, Shimakawa H (1986) High-performance liquid chromatographic determination of 6β-hydroxycortisol in urine. Chem Pharm Bull 34:2522–2527

    Article  CAS  Google Scholar 

  16. Nakamura J, Yakata M (1985) Determination of urinary cortisol and 6β-hydroxycortisol by high performance iquid chrmotography. Clin Chim Acta 149:215–224

    Article  CAS  Google Scholar 

  17. Lykkesfeldt J, Loft S, Poulsen HE (1994) Simultaneous determination of urinary free cortisol and 6β-hydroxycortisol by high-performance liquid chromatography to measure human CYP3A activity. J Chromatogr B 660:23–29

    Article  CAS  Google Scholar 

  18. Inoue S, Inokuma M, Harada T, Shibutani Y, Yoshitake T, Charles B, Ishida J, Yamaguchi M (1994) Simultaneous high-performance liquid chromatographic determination of 6β-hydroxycortisol and cortisol in urine with fluorescence detection and its application for estimating hepatic drug-metabolizing enzyme induction. J Chromatogr B 661:15–23

    Article  CAS  Google Scholar 

  19. Shibata N, Hayakawa T, Takada K, Hoshino N, Minouchi T, Yamaji A (1998) Simultaneous determination of glucocorticoids in plasma or urine by high-performance liquid chromatography with precolumn fluorimetric derivatization by 9-anthroyl nitrile. J Chromatogr B 706:191–199

    Article  CAS  Google Scholar 

  20. Homma M, Beckerman K, Hayashi S, Jayewardene AL, Oka K, Gambertoglio JG, Aweeka FT (2000) Liquid chromatographic determination of urinary 6β-hydroxycortisol to assess cytochrome p-450 3A activity in HIV positive pregnant women. J Pharm Biomed Anal 23:629–635

    Article  CAS  Google Scholar 

  21. Ohno M, Yamaguchi I, Saiki K, Yamamoto I, Azuma J (2000) Specific determination of urinary 6β-hydroxycortisol and cortisol by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry. J Chromatogr B 746:95–101

    Article  CAS  Google Scholar 

  22. Barrett YC, Akinsanya B, Chang S-Y, Vesterqvist O (2005) Automated on-line SPE LC-MS/MS method to quantitate 6beta-hydroxycortisol and cortisol in human urine: use of the 6beta-hydroxycortisol to cortisol ratio as an indicator of CYP3A4 activity. J Chromatogr B 821:159–165

    Article  CAS  Google Scholar 

  23. Lutz U, Bittnera N, Uferb M, Lutz WK (2010) Quantification of cortisol and 6β-hydroxycortisol in human urine by LC-MS/MS, and gender-specific evaluation of the metabolic ratio as biomarker of CYP3A activity. J Chromatogr B 878:97–102

    Article  CAS  Google Scholar 

  24. Furuta T, Matsuzawa M, Shibasaki H, Kasuya Y (2000) Simultaneous determination of 6α- and 6β-hydroxycortisols and 6β-hydroxycortisone in human urine by stable isotope dilution mass spectrometry. J Chromatogr B 738:367–376

    Article  CAS  Google Scholar 

  25. Suzuki A, Shibasaki H, Kasuya Y, Furuta T (2003) Simultaneous determination of endogenous and stable isotope-labelled 6β-hydroxycortisols in human urine by stable isotope dilution mass spectrometry. J Chromatogr B 794:373–380

    Article  CAS  Google Scholar 

  26. Furuta T, Mori C, Suzuki A, Shibasaki H, Yokokawa A, Kasuya Y (2004) Simultaneous determination of 6β-hydroxycortisol and cortisol in human urine by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A activity determined by the cortisol 6β-hydroxylation clearance. J Chromatogr B 80:165–171

    Article  Google Scholar 

  27. Furuta T, Eguchi N, Shibasaki H, Kasuya Y (2000) Simultaneous determination of endogenous and 13C-labelled cortisols and cortisones in human plasma by stable isotope dilution mass spectrometry. J Chromatogr B Biomed Sci Appl 738:119–127

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Takashi Furuta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shibasaki, H., Okamoto, S., Inoue, R. et al. Separation and quantitative determination of 6α-hydroxycortisol and 6β-hydroxycortisol in human urine by high-performance liquid chromatography with ultraviolet absorption detection. Anal Bioanal Chem 402, 2945–2952 (2012). https://doi.org/10.1007/s00216-012-5714-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-012-5714-3

Keywords

Navigation